North America Point-of-care Glucose Testing Market Size & Outlook

The point-of-care glucose testing market in North America is expected to reach a projected revenue of US$ 1,841.5 million by 2030. A compound annual growth rate of 4.3% is expected of North America point-of-care glucose testing market from 2024 to 2030.
Revenue, 2023 (US$M)
$1,373.7
Forecast, 2030 (US$M)
$1,841.5
CAGR, 2024 - 2030
4.3%
Report Coverage
North America

North America point-of-care glucose testing market, 2018-2030 (US$M)

North

North America point-of-care glucose testing market highlights

  • The North America point-of-care glucose testing market generated a revenue of USD 1,373.7 million in 2023.
  • The market is expected to grow at a CAGR of 4.3% from 2024 to 2030.
  • In terms of segment, accu-chek inform ii was the largest revenue generating product in 2023.
  • Freestyle Lite is the most lucrative product segment registering the fastest growth during the forecast period.
  • Country-wise, U.S. is expected to register the highest CAGR from 2024 to 2030.

North America data book summary

Market revenue in 2023USD 1,373.7 million
Market revenue in 2030USD 1,841.5 million
Growth rate4.3% (CAGR from 2023 to 2030)
Largest segmentAccu-chek inform ii
Fastest growing segmentFreestyle Lite
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationAccu Check Aviva Meter, Onetouch Verio Flex, I-STAT, Freestyle Lite, Bayer CONTOUR blood glucose monitoring system, True Metrix, Accu-Chek Inform II, StatStrip
Key market players worldwideRoche, Abbott Laboratories, Nipro Corp, Nova Biomedical, ACON Laboratories, Bayer AG, EKF Diagnostics Holdings PLC

Other key industry trends

  • In terms of revenue, North America region accounted for 40.4% of the global point-of-care glucose testing market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 1,070.6 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Point-of-Care Glucose Testing Market Companies

Name Profile # Employees HQ Website

North America point-of-care glucose testing market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to point-of-care glucose testing market will help companies and investors design strategic landscapes.


Accu-chek inform ii was the largest segment with a revenue share of 18.02% in 2023. Horizon Databook has segmented the North America point-of-care glucose testing market based on accu check aviva meter, onetouch verio flex, i-stat, freestyle lite, bayer contour blood glucose monitoring system, true metrix, accu-chek inform ii, statstrip covering the revenue growth of each sub-segment from 2018 to 2030.


North America generated the highest revenue in global Point-Of-Care (POC) glucose diagnostics/testing market in 2020 and is expected to maintain its dominance over the forecast period. This region is home to several key market players such as Abbott, Nova Biomedical, and Prodigy Diabetes Care, LLC.

This has increased availability of glucose testing products, thereby contributing to the revenue generation. In addition, higher healthcare expenditure by governments on diabetes management is one of the factors responsible for the largest share held by the region in the global market.

Furthermore, local manufacturers are continuously evolving in terms of technological advancements and are incorporating latest technologies, such as Picture Archiving and Communication Systems (PACS) and Electronic Medical Records (EMR), which is expected to drive the market growth during the forecast period.

Reasons to subscribe to North America point-of-care glucose testing market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of North America point-of-care glucose testing market databook

  • Our clientele includes a mix of point-of-care glucose testing market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the North America point-of-care glucose testing market , including forecasts for subscribers. This continent databook contains high-level insights into North America point-of-care glucose testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

North America point-of-care glucose testing market size, by country, 2018-2030 (US$M)

North America Point-of-Care Glucose Testing Market Outlook Share, 2023 & 2030 (US$M)

North America point-of-care glucose testing market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more